Deregulated microRNAs in multiple myeloma

作者: Leonidas Benetatos , George Vartholomatos

DOI: 10.1002/CNCR.26297

关键词:

摘要: MicroRNAs are short noncoding RNAS involved in gene expression regulation under physiological and pathological situations. They bind to mRNA of target genes potential regulators at a post-transcription level through the RNA interference pathway. estimated represent 1% 2% known eukaryotic genome, it has been demonstrated that they pathogenesis neurodegenerative diseases, cancer, metabolism disorders, heart disease. act as tumor suppressors or oncogenes cancer biology. The authors describe current knowledge on microRNA involvement regulatory pathways characterize multiple myeloma gained from vitro vivo studies. These small molecules interact with important factors such p53, SOCS1, IGF-1, IGF-1R, vascular endothelial growth factor, NF-κB, others. As such, microRNAs an attractive therapeutic context interfering networks. Further studies needed better understand their role myelomagenesis potential. Cancer 2012;. © 2011 American Society.

参考文章(68)
Kevin V Morris, Barbora Malecová, Transcriptional gene silencing through epigenetic changes mediated by non-coding RNAs. Current Opinion in Molecular Therapeutics. ,vol. 12, pp. 214- 222 ,(2010)
Francisco Navarro, Judy Lieberman, Small RNAs guide hematopoietic cell differentiation and function. Journal of Immunology. ,vol. 184, pp. 5939- 5947 ,(2010) , 10.4049/JIMMUNOL.0902567
Diamantina Vasilatou, Sotirios Papageorgiou, Vassiliki Pappa, Efstathios Papageorgiou, John Dervenoulas, The role of microRNAs in normal and malignant hematopoiesis. European Journal of Haematology. ,vol. 84, pp. 1- 16 ,(2010) , 10.1111/J.1600-0609.2009.01348.X
Sharathkumar Bhagavathi, Magdalena Czader, MicroRNAs in benign and malignant hematopoiesis. Archives of Pathology & Laboratory Medicine. ,vol. 134, pp. 1276- 1281 ,(2010) , 10.1043/2009-0178-RS.1
John R. Finnerty, Wang-Xia Wang, Sébastien S. Hébert, Bernard R. Wilfred, Guogen Mao, Peter T. Nelson, The miR-15/107 group of microRNA genes: evolutionary biology, cellular functions, and roles in human diseases Journal of Molecular Biology. ,vol. 402, pp. 491- 509 ,(2010) , 10.1016/J.JMB.2010.07.051
Masamichi Ita, H. Dorota Halicka, Toshiki Tanaka, Akira Kurose, Barbara Ardelt, Kuslima Shogen, Zbigniew Darzynkiewicz, Remarkable enhancement of cytotoxicity of onconase and cepharanthine when used in combination on various tumor cell lines Cancer Biology & Therapy. ,vol. 7, pp. 1104- 1108 ,(2008) , 10.4161/CBT.7.7.6172
Muller Fabbri, Carlo M. Croce, George A. Calin, MicroRNAs in the ontogeny of leukemias and lymphomas Leukemia & Lymphoma. ,vol. 50, pp. 160- 170 ,(2009) , 10.1080/10428190802535114
Massimo Negrini, Milena S Nicoloso, George A Calin, MicroRNAs and cancer—new paradigms in molecular oncology Current Opinion in Cell Biology. ,vol. 21, pp. 470- 479 ,(2009) , 10.1016/J.CEB.2009.03.002
Yiming Zhou, Lijuan Chen, Bart Barlogie, Owen Stephens, Xiaosong Wu, David R. Williams, Marie-Astrid Cartron, Frits van Rhee, Bijay Nair, Sarah Waheed, Mauricio Pineda-Roman, Yazan Alsayed, Elias Anaissie, John D. Shaughnessy, High-risk myeloma is associated with global elevation of miRNAs and overexpression ofEIF2C2/AGO2 Proceedings of the National Academy of Sciences. ,vol. 107, pp. 7904- 7909 ,(2010) , 10.1073/PNAS.0908441107
Leonidas Benetatos, Eleftheria Hatzimichael, Aggeliki Dasoula, George Dranitsaris, Stavroula Tsiara, Maria Syrrou, Ioannis Georgiou, Konstantinos L. Bourantas, CpG methylation analysis of the MEG3 and SNRPN imprinted genes in acute myeloid leukemia and myelodysplastic syndromes Leukemia Research. ,vol. 34, pp. 148- 153 ,(2010) , 10.1016/J.LEUKRES.2009.06.019